Cargando…

Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations

BACKGROUND: Kirsten rat sarcoma viral oncogene homolog (KRAS) and epidermal growth factor receptor (EGFR) are the two most frequent and well-known oncogene of lung adenocarcinoma. The purpose of this study is to compare the characteristics measured with dual-energy spectral computed tomography (DESC...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meng, Zhang, Li, Tang, Wei, Duan, Jian-Chun, Jin, Yu-Jing, Qi, Lin-Lin, Wu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884869/
https://www.ncbi.nlm.nih.gov/pubmed/31783917
http://dx.doi.org/10.1186/s40644-019-0261-1
_version_ 1783474637611466752
author Li, Meng
Zhang, Li
Tang, Wei
Duan, Jian-Chun
Jin, Yu-Jing
Qi, Lin-Lin
Wu, Ning
author_facet Li, Meng
Zhang, Li
Tang, Wei
Duan, Jian-Chun
Jin, Yu-Jing
Qi, Lin-Lin
Wu, Ning
author_sort Li, Meng
collection PubMed
description BACKGROUND: Kirsten rat sarcoma viral oncogene homolog (KRAS) and epidermal growth factor receptor (EGFR) are the two most frequent and well-known oncogene of lung adenocarcinoma. The purpose of this study is to compare the characteristics measured with dual-energy spectral computed tomography (DESCT) in lung adenocarcinoma patients who have KRAS and EGFR gene mutations. METHODS: Patients with surgically resected lung adenocarcinoma (n = 72) were enrolled, including 12 patients with KRAS mutations and 60 patients with EGFR mutations. DESCT quantitative parameters, including the CT number at 70 keV, the slopes of the spectral attenuation curves (slope λ HU), normalized iodine concentration (NIC), normalized water concentration (NWC), and effective atomic number (effective Z), were analyzed. A multiple logistic regression model was applied to discriminate clinical and DESCT characteristics between the types of mutations. RESULTS: The KRAS mutation was more common in people who smoked than the EGFR mutation. Nodule type differed significantly between the KRAS and EGFR groups (P = 0.035), and all KRAS mutation adenocarcinomas were solid nodules. Most DESCT quantitative parameters differed significantly between solid nodules and subsolid nodules. CT number at 70 keV, slope λ HU, NIC, and effective Z differed significantly between the KRAS and EGFR groups (P = 0.006, 0.017, 0.013 and 0.010) with solid lung adenocarcinoma. Multivariate logistic analysis of DESCT and clinical features indicated that besides smoking history, the CT value at 70 keV (OR = 0.938, P = 0.009) was significant independent factor that could be used to differentiate KRAS and EGFR mutations in solid lung adenocarcinoma. CONCLUSIONS: DESCT would be a potential tool to differentiate lung adenocarcinoma patients with a KRAS mutation from those with an EGFR mutation.
format Online
Article
Text
id pubmed-6884869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68848692019-12-03 Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations Li, Meng Zhang, Li Tang, Wei Duan, Jian-Chun Jin, Yu-Jing Qi, Lin-Lin Wu, Ning Cancer Imaging Research Article BACKGROUND: Kirsten rat sarcoma viral oncogene homolog (KRAS) and epidermal growth factor receptor (EGFR) are the two most frequent and well-known oncogene of lung adenocarcinoma. The purpose of this study is to compare the characteristics measured with dual-energy spectral computed tomography (DESCT) in lung adenocarcinoma patients who have KRAS and EGFR gene mutations. METHODS: Patients with surgically resected lung adenocarcinoma (n = 72) were enrolled, including 12 patients with KRAS mutations and 60 patients with EGFR mutations. DESCT quantitative parameters, including the CT number at 70 keV, the slopes of the spectral attenuation curves (slope λ HU), normalized iodine concentration (NIC), normalized water concentration (NWC), and effective atomic number (effective Z), were analyzed. A multiple logistic regression model was applied to discriminate clinical and DESCT characteristics between the types of mutations. RESULTS: The KRAS mutation was more common in people who smoked than the EGFR mutation. Nodule type differed significantly between the KRAS and EGFR groups (P = 0.035), and all KRAS mutation adenocarcinomas were solid nodules. Most DESCT quantitative parameters differed significantly between solid nodules and subsolid nodules. CT number at 70 keV, slope λ HU, NIC, and effective Z differed significantly between the KRAS and EGFR groups (P = 0.006, 0.017, 0.013 and 0.010) with solid lung adenocarcinoma. Multivariate logistic analysis of DESCT and clinical features indicated that besides smoking history, the CT value at 70 keV (OR = 0.938, P = 0.009) was significant independent factor that could be used to differentiate KRAS and EGFR mutations in solid lung adenocarcinoma. CONCLUSIONS: DESCT would be a potential tool to differentiate lung adenocarcinoma patients with a KRAS mutation from those with an EGFR mutation. BioMed Central 2019-11-29 /pmc/articles/PMC6884869/ /pubmed/31783917 http://dx.doi.org/10.1186/s40644-019-0261-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Meng
Zhang, Li
Tang, Wei
Duan, Jian-Chun
Jin, Yu-Jing
Qi, Lin-Lin
Wu, Ning
Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
title Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
title_full Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
title_fullStr Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
title_full_unstemmed Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
title_short Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
title_sort dual-energy spectral ct characteristics in surgically resected lung adenocarcinoma: comparison between kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884869/
https://www.ncbi.nlm.nih.gov/pubmed/31783917
http://dx.doi.org/10.1186/s40644-019-0261-1
work_keys_str_mv AT limeng dualenergyspectralctcharacteristicsinsurgicallyresectedlungadenocarcinomacomparisonbetweenkirstenratsarcomaviraloncogenemutationsandepidermalgrowthfactorreceptormutations
AT zhangli dualenergyspectralctcharacteristicsinsurgicallyresectedlungadenocarcinomacomparisonbetweenkirstenratsarcomaviraloncogenemutationsandepidermalgrowthfactorreceptormutations
AT tangwei dualenergyspectralctcharacteristicsinsurgicallyresectedlungadenocarcinomacomparisonbetweenkirstenratsarcomaviraloncogenemutationsandepidermalgrowthfactorreceptormutations
AT duanjianchun dualenergyspectralctcharacteristicsinsurgicallyresectedlungadenocarcinomacomparisonbetweenkirstenratsarcomaviraloncogenemutationsandepidermalgrowthfactorreceptormutations
AT jinyujing dualenergyspectralctcharacteristicsinsurgicallyresectedlungadenocarcinomacomparisonbetweenkirstenratsarcomaviraloncogenemutationsandepidermalgrowthfactorreceptormutations
AT qilinlin dualenergyspectralctcharacteristicsinsurgicallyresectedlungadenocarcinomacomparisonbetweenkirstenratsarcomaviraloncogenemutationsandepidermalgrowthfactorreceptormutations
AT wuning dualenergyspectralctcharacteristicsinsurgicallyresectedlungadenocarcinomacomparisonbetweenkirstenratsarcomaviraloncogenemutationsandepidermalgrowthfactorreceptormutations